Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Stage I ovarian cancer: Comparison of laparoscopy and laparotomy on staging and survival
1Service de Chirurgie Gynecologique et Cancerologique, Hopital Europeen Georges Pompidou, Faculte de Medecine Necker Enfants Malades, Paris
2Centre Investigation Clinique, Hopital Europeen Georges Pompidou, Paris
3Matemite de la Conception, Marseille
4Centre Claudius Regaud, Toulouse, France
*Corresponding Author(s): F. Lecuru E-mail:
Objective: The aim of this study was to compare staging accurateness as well as survival when managing early ovarian cancers by laparoscopy or laparotomy.
Material and methods: We have conducted a retrospective and multicentric study in France. Only Stage I ovarian epithelial cancers operated on from January 1, 1985 to December 31, 1999 were taken into account. Respondents had to fill in a form detailing in each case the surgical access; the surgical acts performed during the initial intervention as well as data on the patient's follow-up. Lack of follow-up or final Stage > I were considered as exclusion criteria. Data were recorded and analysed with SPSS 7.5 and STATA (Stata statistical sofware 7.0). (ANOVA, chi-square test or Fisher's exact test and log-rank test).
Results: 105 cases were included: 14 patients were exclusively operated on by laparoscopy (group 1), 13 other patients were subjected to a conversion from laparoscopy to laparotomy (group 2) and 78 patients exclusively underwent laparotomy (group 3). Patients in group 3 were significantly more frequently postmenopausal and had larger lesions. Cyst rupture was rare during laparoscopy (21%) and the use of an endobag was achieved in only 21% of the patients in group 1. Radical treatment was significantly more frequent in group 3 when compared to group 1 (67% vs 23%, p < 0.05). Laparoscopy was not adequate for staging since no lymphadenectomy was carried out by this approach. However, only 27% of patients subjected to an open approach underwent lymphadenectomy and omentectomy. The outcome in terms of survival was similar in the three groups with a mean follow-up period of 1,221 days (+/- 832) (p = 0.1).
Conclusion: Laparoscopic management of early ovarian cancer is poorly efficient in staging although disease-free survival does not seem to be affected. Further evaluation of laparoscopy in this indication is needed.
Ovarian cancer; Stage I; Laparoscopy; Laparotomy; Staging; Survival
F. Lecuru,P. Desfeux,S. Camatte,A. Bissery,F. Robin,B. Blanc,D. Querleu. Stage I ovarian cancer: Comparison of laparoscopy and laparotomy on staging and survival. European Journal of Gynaecological Oncology. 2004. 25(5);571-576.
[1] Canis M., Botschorishvili R., Manhes H., Wattiez A., Mage G., Pouly J.L., Bruhat M.A.: "Management of adnexal masses: role and risk of laparoscopy". Seminars Surg. Oncol., 2000, 19, 28.
[2] Yuen P., Yu K., Yip S., Lau W., Rogers M., Chang A.: "A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses". Am. J. Obstet. Gynecol. 1997, 177, 109.
[3] Querleu D., Leblanc E.: "Laparoscopic infrarenal paraaortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube". Cancer, 1994, 73, 1467.
[4] Possover M., Krause N., Plaul K.. Klihne-Heid R., Schneider A.; "Laparoscopic paraaortic and pelvic lymphadenectomy: experience with 150 patients and review of literature". Gynecol. Oneal., 1998,71, 19.
[5] Scribner D.. Walker J.. Jonhson G., McMeekin S., Gold M., Mannel R.: "Laparoscopic and paraaortic lymph node dissection analysis of the first 100 cases". Gynecol. Oneal., 2001, 82, 498.
[6] Pomel C., Provencher D., Dauplat J., Gauthier P., Le Bouedec G., Drouin P. et al.: "Laparoscopic staging of early ovarian cancer" Gynecol. Oneal., 1995, 58, 301.
[7] Young R., Decker D., Wharton T., Piver S., Sindelar W., Edwards B., Smith J.: "Staging laparotomy in early ovarian cancer". JAMA, 1983, 250, 3072.
[8] Le T., Adolph A., Krepart G., Lotocki R., Heywood M.: "The benefits of comprehensive surgical staging in the management of early stage epithelial ovarian carcinoma". Gynecol. Oneal., 2002, 85, 351.
[9] Mathew G., Watson D., Rofe A., Ellis T., Jamieson G.: "Advers impact of pneumoperitoneum on intraperitoneal implantation and growth of tumour cell suspension in an experimental model". Aust. N. Z. J. Surg., 1997, 67, 289.
[10] Lehner R.,W enzl R.,H einzl H., Husslein P.,S evelda P.: "Influence of delayed staging laparotomy after laparoscopic removal of ovarian masses later found malignant". Obstet. Gynecol., 1998, 92, 967
[11] Blanc B., Boubli L., D'Ercole L., Nicoloso E.: "Laparoscopic management of malignant ovarian cysts: A 78 cases national survey. Part 1: pre-operative and laparoscopic evaluation". Eur. J. Obstet. Gynecol. Biol. Reprod., 1994, 56, 177.
[12] Maiman M., Seltzer V., Boyce J.: "Laparoscopic excision of ovarian neoplasms subsequently found to be malignant". Obstet Gynecol., 1991, 77, 565.
[13] Wang P., Luan C., Lin G., Ng H., Chao H.: "Risks factors contributing to early occurrence of portsite metastases of laparoscopic surgery for malignancy". Gynecol. Oneal., 1999, 72, 38.
[14] Leminen A., Lehtovirta P.: "Spread of ovarian cancer after laparoscopic surgery: report of eight cases". Gynecol. Oneal., 1999, 75, 387.
[15] Leblanc E., Querleu D., Narducci F., Chauvet M.P., Chevalier A., Lesoin A. et al.: "Surgical staging of early invasive epithelial ovarian tumors". Seminars Surg. Oneal., 2000, 19, 36.
[16] Vergote I., De Brabanter J., Fyles A., Beterlsen K., Einhorn N., Sevelda P. et al.: "Prognostic importance of degree of differentiation and cyst rupture in Stage I invasive epithelial ovarian carcinoma". Lancet, 2001, 357, 176.
[17] Jacobi C., Wildbrett P., Volk T., Miiller J.M.: "Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model". Surg. Endosc., 1999, 13, 1021.
[18] YoshinakaA., Fukasawa I.,S akamoto T.,T anaka M., Ota Y., Inaba N.:'The fertility and pregnancy outcomes of the patients who underwent preservative operation followed by adjuvant chemotherapy for malignant ovarian tumors". Arch. Gynecol. Obstet., 2000, 264, 124.
[19] Morice P., Wicart-Poque F., Rey A., El- Hassan J., Pautier P., Lhomme C. et al.: "Results of conservative treatment in epithelial ovarian carcinoma". Cancer, 2001, 92, 2412.
[20] Burghardt E., Girardi F.,L ahousen M., Tamussino K.,S tettner H.: "Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer". Gynecol. Oneal., 1991, 40, 103.
[21] Benedetti-Panici P.,M aneschi F.,S cambia G., Greggi S.,M ancuso S.: "Anatomic abnormalities of the retroperitoneum encountered during aortic and pelvic lymphadenectomy". Obstet. Gynecol., 1993, 170, 111.
[22] Petru E., Lahousen M., Tamussino K., Pickel H., Stranzl H., Stettner H., Winter R.: "Lymphadenectomy in Stage I ovarian cancer" Am. J. Obstet. Gynecol., 1994, 170, 656.
[23] Le Bouedec G., Fondrinier E., Kauffman P., Mansoor A., Dauplat J.: "Pelvic and paraortic lymphadenectomy in ovarian cancer" Presse Med., 1992, 21, 745.
[24] Cass I., Li A., Runowicz C., Fields A., Goldberg G., Leuchter R et al.: "Pattern of lymph node metastases in clinically unilateral Stage I invasive epithelial ovarian carcinomas". Gynecol. Oncol., 2001, 80, 56.
[25] Childers J., Lang J., Surwitt E., Hatch K.: "Laparoscopic surgical staging of ovarian cancer". Gynecol. Oncol., 1995, 59, 25.
[26] Schlaert J.B., Spirtos N., Carson L., Boike G., Adamek T., Stonebaker B.: "Laparoscopic retroperitoneal lymphadenectomy in women with cervical cancer: A gynecologic oncology group study". Gynecol. Oncol., 2002, 85, 81.
[27] Soper J., Johnson P., Johnson V.: "Comprehensive restagmg laparotomy in women with apparent early ovarian carcinoma". Obstet. Gynecol., 1992, 80, 949.
[28] Stier E., Barakat R., Curtin J.: "Laparotomy to complete staging of presumed early ovarian cancer". Obstet. Gynecol., 1996, 87, 737.
[29] Finn C., Luesley D., Buxton E., Blackledge G., Kelly K., Dunn J., Wilson S.: "Is Stage I epithelial ovarian cancer overtreated both surgically and systematically? Results of a five year cancer registry review". Br. J. Obstet. Gynaecol., 1992, 99, 54.
[30] Le T., Krepart G.V., Lotocki R.J., Heywood M.S.: "Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?". Gynecol. Oneal., 1999, 74, 252.
[31] Gutlrrie D., Davy M.L., P hilips P.R.: "A study of 656 patients with early ovarian cancer". Gynecol. Oneal., 1984, 17, 363.
[32] Ahmed F., Wiltshaw E., A'Hern R., Nicol B., Shepherd J., Blake P. et al.: "Natural history and prognosis of untreated stage I epithelial ovarian cancer". J. Clin. Oneal., 1996, 14, 2968.
[33] Lecuru F., Agostini A., Camatte S., Robin F., Aggerbeck M., Jais J.P et al.: "Impact of pneumoperitoneum on visceral metastasis rate and survival". Br. J. Obstet. Gynaecol., 2001, 108, 733.
[34] Fowler J., Carter J., Carlson J., Maslonkovski R., Byers L., Carson F., Twiggs L.: "Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study". Gynecol. Oneal., 1993, 51, 187.
[35] Childers J., Nasseri A., Surwitt E.: "Laparoscopic management of suspicious adnexal masses". Am. J. Obstet. Gynecol., 1996, 175, 1451.
Top